Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection

NCT00306293 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00306293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00306293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
February 20, 2006
Completion date
November 27, 2006
Enrollment
70 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis